The global small molecule API market is expected to grow at a significant CAGR during the forecast period (2021-2027). An organic substance having a molecular weight of less than 1 nm that aids in the regulation of biological processes is known as a small molecule active pharmaceutical ingredient (API). It's made to deliver a wide range of macromolecules with potent therapeutic effects at low doses, sometimes as low as ten milligrammes and often as low as micrograms. Small molecules are administered orally and are easily detected by the body. Amino acids, monosaccharides, and other components make up small molecules. The market is being driven by the rising prevalence of chronic diseases such as diabetes, cancer, and heart and cardiovascular disorders, as well as the growing geriatric population. 

As synthetic active pharmaceutical ingredients are made from low-cost raw materials, synthetic/chemical small molecule APIs have a cheap production cost. Many macromolecules and monosaccharides make up synthetic small molecule API. Synthetic small-molecule pharmaceuticals are more important and effective than other types of medications. The market is growing owing to the rising prevalence of cardiovascular disorders. Unhealthy eating habits, cigarette use, and physical inactivity are only a few of the key causes of cardiovascular disease, which elevate blood pressure and blood glucose levels, resulting in overweight and obesity. According to the World Health Organization, heart attacks and strokes account for four out of every five cardiovascular fatalities, with one-third of these deaths occurring in adults under the age of 70. As a result, the demand for small molecule API will increase during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Albemarle Corp., Allergan plc, and Aurobindo Pharma, among others 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Small Molecule API Market Report Segmentation

By Type

• Synthetic/Chemical API

• Biological API

By Application 

• Cardiology

• Oncology

• Infectious Diseases

• Autoimmune Diseases

• Pulmonology

• Dermatology

• Others 

Global Small Molecule API Market by Region